Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells.
about
Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of ActionNovel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 TatGinsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activationGinseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in ratsAnti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet.Compound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cellsGinsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis.A gut microbial metabolite of ginsenosides, compound K, induces intestinal glucose absorption and Na(+) /glucose cotransporter 1 gene expression through activation of cAMP response element binding protein.Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLRPharmacological effects of ginseng on liver functions and diseases: a minireviewTaurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.Compound K Attenuates the Development of Atherosclerosis in ApoE(-/-) Mice via LXRα ActivationIntestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway.Chinese herbal medicine on dyslipidemia: progress and perspective.Mass Spectrometry-Based Metabolomic and Lipidomic Analyses of the Effects of Dietary Platycodon grandiflorum on Liver and Serum of Obese Mice under a High-Fat Diet.Metabolism of ginseng and its interactions with drugsAMP-activated protein kinase: An emerging target for ginsengInteractions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management.The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells.Ginseng Metabolites on Cancer Chemoprevention: An Angiogenesis Link?20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.Pectinase-Processed Ginseng Radix (GINST) Ameliorates Hyperglycemia and Hyperlipidemia in High Fat Diet-Fed ICR MiceAn active part of Artemisia sacrorum Ledeb. attenuates hepatic lipid accumulation through activating AMP-activated protein kinase in human HepG2 cells.Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats.Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.Compound K induced apoptosis via endoplasmic reticulum Ca2+ release through ryanodine receptor in human lung cancer cells.
P2860
Q28072623-40DA2559-766C-4929-A9B6-A3C1F5BA59D2Q28478994-F4405D00-6207-4DCD-BCFB-98B6D851F419Q28539497-0E2A84D7-EB12-44EF-AF37-7E6B62DDC6B6Q34438937-1CF30C73-89E4-4E64-9F65-EDEDFEF5D1D9Q34685423-16B0675A-AD39-4963-8A66-7CBE67D863E8Q35002191-02B27441-A4A0-4DC9-873E-2752B846AC9AQ35146624-82A104F6-38F8-4C32-B328-C5D72B50EDC2Q35544750-08131426-36DF-4789-ABA2-6CD0791A612FQ35689614-A119A94B-9C6D-4A16-A615-9651795652F9Q36246669-6CB83B72-17F8-4AA9-9944-A6394A15A110Q36431073-17395E65-209F-4554-B363-0EC3946DAB06Q37134445-25B01C65-2EC2-4E17-9FE5-41D3B5BF9043Q37295219-F7890AE3-D7A6-489F-ADCC-3461D13D2DCEQ37618856-198B873B-5545-492F-8DDF-1AD9B4AA103EQ37628465-45E9FBF7-DB07-4E66-941F-D0A8D1029754Q37880925-FE75058C-9135-4A2F-BE0E-C6A05F51CB2DQ38205759-2A8A0BBB-E4F3-45AC-B557-AD8DE471CE19Q38283110-8ACF8B84-3CD2-4FFE-9C74-BC38D6F41D5DQ38401551-EB399294-DD47-4816-889C-FFA5DB1792C0Q38700575-C1156FF0-0626-4713-A060-7F9AA2E5A05BQ38995606-4E434D78-E40E-4B83-8644-22CEB8F43C1DQ39101221-7B7EC595-42A2-42D5-84BD-BA3AF10741FAQ42040754-9FB25121-36F9-4AC0-8AC1-CF5A5AEC920FQ43169937-2CE67E9F-8EA1-4359-9BD9-6C7F916F60C6Q51159954-8CC743F8-4941-45BA-9797-0F8BEAF71B33Q52649002-025C2042-2957-4F0C-9651-25DC3754C921Q52714634-880BF312-300D-4C7F-957F-3C1C619AC5A7
P2860
Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Compound K, intestinal metabol ...... ation in human hepatoma cells.
@en
Compound K, intestinal metabol ...... ation in human hepatoma cells.
@nl
type
label
Compound K, intestinal metabol ...... ation in human hepatoma cells.
@en
Compound K, intestinal metabol ...... ation in human hepatoma cells.
@nl
prefLabel
Compound K, intestinal metabol ...... ation in human hepatoma cells.
@en
Compound K, intestinal metabol ...... ation in human hepatoma cells.
@nl
P2093
P356
P1476
Compound K, intestinal metabol ...... ation in human hepatoma cells.
@en
P2093
Do Yeon Kim
Hai Dan Yuan
In Kyung Chung
Sung Hyun Chung
P304
P356
10.1021/JF802867B
P407
P577
2009-02-01T00:00:00Z